当前位置: X-MOL 学术iScience › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Current Status of COVID-19 Therapies and Drug Repositioning Applications.
iScience ( IF 4.6 ) Pub Date : 2020-06-20 , DOI: 10.1016/j.isci.2020.101303
Ozlem Altay 1 , Elyas Mohammadi 2 , Simon Lam 3 , Hasan Turkez 4 , Jan Boren 5 , Jens Nielsen 6 , Mathias Uhlen 1 , Adil Mardinoglu 7
Affiliation  

The rapid and global spread of a new human coronavirus (SARS-CoV-2) has produced an immediate urgency to discover promising targets for the treatment of COVID-19. Drug repositioning is an attractive approach that can facilitate the drug discovery process by repurposing existing pharmaceuticals to treat illnesses other than their primary indications. Here, we review current information concerning the global health issue of COVID-19 including promising approved drugs and ongoing clinical trials for prospective treatment options. In addition, we describe computational approaches to be used in drug repurposing and highlight examples of in silico studies of drug development efforts against SARS-CoV-2.



中文翻译:

COVID-19 疗法和药物重新定位应用的现状。

新型人类冠状病毒 (SARS-CoV-2) 在全球范围内的迅速传播,迫切需要发现治疗 COVID-19 的有希望的靶点。药物重新定位是一种有吸引力的方法,可以通过重新利用现有药物来治疗主要适应症以外的疾病,从而促进药物发现过程。在这里,我们回顾了有关 COVID-19 全球健康问题的最新信息,包括有前途的批准药物和正在进行的前瞻性治疗方案的临床试验。此外,我们描述了用于药物再利用的计算方法,并重点介绍了针对 SARS-CoV-2 药物开发工作的计算机研究示例。

更新日期:2020-06-20
down
wechat
bug